About
There are globally over 300 million people with high intra-ocular pressure (IOP), which can lead to glaucoma and blindness. Glaucoma is mostly asymptomatic and disease progress can go unnoticed because the build up of pressure is gradual and painless. People often do not detect a change in vision until substantial loss of sight has occurred. There is a need for novel solutions in glaucoma screening, measuring and monitoring which are essential to diagnosis, treatment and follow-up. Our next generation solution for glaucoma is under development.
Technologies
Outlook
Google Analytics
OpenSSL
reCAPTCHA
Google Font API
Typekit
Apache
Mobile Friendly
Keywords
medical equipment manufacturing
vision monitoring
high intra-ocular pressure
healthcare innovation
medical devices
pressure measurement
vision health solutions
disruptive medical device
vision health
early detection
vision loss prevention technology
research collaboration in ophthalmology
next-generation ophthalmic device
glaucoma follow-up
collaborative research
glaucoma screening
ophthalmology technology
iop measurement
ophthalmic device
patient care
monitoring solutions
healthtech
medical diagnostics
glaucoma monitoring
state-of-the-art ophthalmic technology
finnish medical technology
glaucoma detection
ophthalmic research
medical research
vision care
Company Information
-
Employees 3
Location
1 Mikkolantie, Helsinki, Uusimaa, Finland, 00640
